TruthArchive.ai - Related Video Feed

So once I knew it was safe, then I started using it, and then I found it worked. And then, yeah, all in all, I treated well over 6,000 patients, and everybody that got early treatment stayed out of the hospital. I also had patients come in that were really sick in the second week. And that was such a learning experience for me because normally if somebody walked into my office with an oxygen saturation in the low 80s, I would call an ambulance. But I had patients who were refusing to go to the hospital, and I had to give them the option to possibly die in my office, which is scary. But we saved them. I mean, we just threw the kitchen sink at him, and we didn't have monoclonal antibodies. So we brought him in every day. We did IV steroids. We did IV antibiotics. We gave him home oxygen. We gave him high dose of ivermectin.

In the early days of COVID, I learned about Ivermectin's potential in cancer treatment. I met Paul, a healthy marathoner diagnosed with stage 4 prostate cancer shortly after his second Pfizer vaccine. After exhausting traditional treatments, he was given no options and referred to hospice. A friend suggested I speak with him for support. I recommended Ivermectin, which he obtained in Tennessee without telling his oncologist. Over time, he reported slight improvements, and during a follow-up, his PSA levels dropped significantly, indicating a biochemical remission. Despite some health issues, including TIAs, he eventually saw a cardiologist and improved further. Nine months later, he was dancing and had no new cancer growth, with some bone metastases gone. He felt so well that he said if he didn't know he had cancer, he wouldn't suspect it.

Speaker 0: What about vaccine injury? The ones that actually took the shots. What did you see there? Speaker 1: Massive. I didn't know it was possible for a human to die so horrifically and so quickly before they rolled out the mRNA injections. It was insane. Patient the worst of them were the ones called it sepsis, but it was, like, instant multi organ failure. Like, within hours, patients would die of liver, lung, kidney, all at once failure, respiratory failure. It was like their some of the records, the emergency crew that found them, it's like their body tried to reject everything. And and some of these cases, like, their family would be there thirty minutes before, and then within an hour, they're dead. And then there were patients coming in with seizures like I've never seen before. We couldn't control some of them. Days, patients would be seizing, and no medications would stop it. And eventually, they kind of had to put down. They called it encephalitis or encephalopathy. And then later on, even the coding information organization, AHIMA, admitted COVID nineteen associated encephalitis. There were blood clots, strokes. The clots were insane. Never seen clots like that before. Even the interventional radiologist that were going in with, you know, they have angiopathies and, you know, different scopes where they can do, like, heart interventions and put stents in, like a carotid artery if you have a stroke going to your brain. They normally, it's rare to have more than one stent go in, and they were documenting, you know, multiple locations all at once. They had heart attack cases that were like that where they, you know, they needed massive amounts of stents that they never needed before. There were people in their twenties that had been hiking that were totally healthy, had been running marathons that suddenly needed an a leg amputated because they had massive blood clot going from their hip all the way down to their leg, and it couldn't be saved. So that happened. There were some cases of overnight spinal gangrene, which I've never seen before. And you can't amputate, you know, the spine when it goes gangrenous. Normally, cut out tissue that's dying like that, so it prevents further infection. And they didn't know what to do. The only thing they could do was, you know, do a basically replace the that part of your spine with an implant. That's the best they could do. Yeah. It was really intense. And I didn't question the vaccines as much as I should have. I started to about the flu shot way back in 2004. But with the pressure to get the COVID nineteen shot, I started looking into what it could do, and I I knew I didn't want anything to do with this experimental mRNA thing. And when I started looking into the experts that were saying, well, this is what this potential vaccine could do. This is what the research says. I was looking at the vaccine trials and what's happening to those patients and the Guill Barre that was happening and the strokes that were happening. And so I kind of knew to look for that when the vaccine came out. And the doctors were, you know, baffled. They weren't connecting the dots. But to me, knowing what the potential causes or potential symptoms of a vaccine injury could be, we a hundred percent had all the things that I just described. But doctors would never tell you that. They would just say it's a stroke. It's a heart attack. It's a blood clot, and they would never connect the two. Speaker 0: Is there anything that would make you take a vaccination of any kind ever again? Speaker 1: They would have to kill me. Nothing. Nothing would make me take it.

Speaker 0 describes being on the front line in Miami and using vitamin C as a go-to, questioning whether it is taken orally and in what amount. Speaker 1 confirms oral administration and notes taking a lot of vitamin C due to exposure and concern. Speaker 0 explains that a scientist contacted them after testing their sample, asking if they noticed their Bifidobacteria levels had risen fourfold. The speaker reveals they had been taking high dosages of vitamin C, which prompted a shift in approach. While dealing with treating COVID-19 patients and assessing stools in high-risk and severe cases, they decided to consult naturopaths and collect stool samples before and after treatment to evaluate the impact. Speaker 1 recounts that they began making phone calls, offering to pay for stool samples before and after on patients treated with vitamin C. They collected about twenty to twenty-five samples and observed that vitamin C increased Bifidobacteria. This finding led to publishing research showing that vitamin C increases Bifidobacteria in vitro, and they extended this to show an increase in patients as well. Key points: - Vitamin C was used as a primary approach by a frontline clinician in Miami, with emphasis on oral administration. - A scientist noted a fourfold increase in Bifidobacteria, prompting a change in strategy toward investigating vitamin C’s effects. - They initiated a program to collect stool samples before and after vitamin C treatment in COVID-19 patients, collaborating with naturopathic practitioners and funding the stool analyses themselves. - About 20–25 samples were analyzed, revealing that vitamin C increased Bifidobacteria. - They published a paper demonstrating the increase of Bifidobacteria with vitamin C both in vitro and in patient samples.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a textile dye but has shown significant benefits for mitochondria. It's surprising to see effective treatments being overlooked, raising questions about the medical industry's priorities. Why are cures that aren't profitable often ignored or demonized? This situation highlights a failure in our medical institutions to promote genuinely effective solutions.

At home, it is recommended to treat viral replication by giving remedies like zinc and hydroxychloroquine, ivermectin, which reduce the spread of the disease. However, the protocol followed was different. No treatment was given until hospitalization, where ventilators and Remdesivir were used. It is known that Remdesivir can be harmful, as it caused side effects in Ebola patients. The drug was manipulated and made standard of care, leading to kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths during the pandemic were often attributed to kidney failure, which was caused by Remdesivir, not the virus itself.

I worked in a community hospital that cared for marginalized communities during COVID. I convinced the Chairman of the Board to turn the entire hospital into an ICU to handle the expected surge. Meanwhile, I co-founded the FLCCC with Dr. Paul Maric and Dr. Pierre Kory to develop guidelines and protocols. We had great success using the MAF plus protocol, cortisone-like agents, vitamin C, and repurposed drugs like Ivermectin. My hospital's mortality rate was only 4.4%, much lower than average.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a fabric dye but is now known to have significant effects on mitochondria. It's surprising to discover that many effective treatments are overlooked or demonized, raising questions about the motives behind our medical institutions. Why are these cures not promoted when they are not profitable?

The speaker discusses promising results for high dose vitamin C in cancer treatment. A recent study on high dose vitamin C shows so much promise, and there have already been human trials underway in which patients who received high dose vitamin C did have drastically improved outcomes: they lived longer and they had less symptoms from the chemo. Mechanistically, the vitamin C literally wipes out the cancer cells via, like, four distinct very strong mechanisms. The speaker also notes that it is very safe as well. In addition, the speaker mentions other natural cancer therapies: ivermectin, fenbendazole, and now dandelion root extract, stating that all of these show extreme promise for natural cancer treatments.

It's frustrating that effective treatments used globally aren't considered here. A doctor mentioned that many treatments don't work, and with a high mortality rate, there's little to lose by trying new options. Patients often present with severe breathing difficulties and thick mucus in their lungs, visible on X-rays. Proven treatments exist, like high-dose IV vitamin C, which has shown success in trials, but these are often dismissed. Instead, patients are frequently sedated and placed on ventilators. Despite the historical skepticism surrounding vitamin C, it has potential benefits that are overlooked, leaving many to question the current medical approach.

In just 10 weeks, he saw significant improvements in his health, losing over 40 pounds and getting off all prescription medications. His blood work, kidney and liver function, immune system, and skin tone all improved. He no longer needed a CPAP machine, was no longer prediabetic, and had normal blood pressure without medication. His life expectancy nearly tripled, giving him a new lease on life.

Speaker 1 was deemed inoperable, incurable, palliative, and terminally ill, with a couple of months to live without treatment. Speaker 0 was also terminal after cancer spread to the liver and lungs and did not want to undergo chemo again. Metabolic therapy can manage the disorder and correct other problems like diabetes, high blood pressure, and hypertension, so you get healthier as you degrade your tumor. Speaker 0's cancer levels went down to 0.05, which is almost nothing, and was cancer-free by December 2020. Speaker 1 is doing really well fifteen to eighteen months later. Speaker 3's wife had stage four cancer and was cancer-free a year later using metabolic therapies. Fasting and metabolic therapy combined with chemo can lower chemo dosages while maintaining therapeutic efficacy. If you want to live and get healthy, you do metabolic therapy, but "they" will not allow the entire system to change.

An independent third party determined outcomes were 24% better than the peer group. There was a discussion about videotaping, with someone stating they couldn't videotape what was happening. Doctors were not blocked from prescribing Inventon or any medical treatment they found best for the patient.

It's frustrating that effective treatments aren't being utilized. A conversation with a doctor revealed that many current treatments aren't working, and there's skepticism about trying new methods. Despite the high mortality rate, some believe it's worth exploring alternatives. Patients often present with severe breathing issues and thick mucus in their lungs, which complicates oxygen transfer. Proven treatments, like high-dose IV vitamin C, have shown success in trials but are dismissed here. Instead, patients are often sedated and placed on ventilators. There's a reluctance to accept these treatments, despite their potential benefits.

Massive. I didn't know it was possible for a human to die so horrifically and so quickly before they rolled out the mRNA injections. Within hours, patients would die of liver, lung, kidney, all at once failure, respiratory failure. There were patients coming in with seizures like I've never seen before. Days, patients would be seizing, and no medications would stop it. They called it encephalitis or encephalopathy. AHIMA, admitted COVID nineteen associated encephalitis. The clots were insane. Never seen clots like that before. Overnight spinal gangrene. I didn't question the vaccines as much as I should have. I started looking into what it could do. I didn't want anything to do with this experimental mRNA thing. And the doctors were, you know, baffled. They weren't connecting the dots. They would just say it's a stroke. It's a heart attack. It's a blood clot, and they would never connect the two. They would have to kill me. Nothing. Nothing would make me take it.

To treat viral infections at home, zinc and its enhancers, like hydroxychloroquine and ivermectin, should be used, as they significantly reduce disease spread. However, the established protocol delayed treatment until hospitalization, where patients received ventilators and remdesivir—both potentially lethal. Remdesivir had previously shown harmful effects in Ebola trials, leading to its discontinuation due to a high rate of severe side effects. Despite this, it became standard care during the pandemic, contributing to kidney failure, heart failure, and organ collapse in patients. Many who died were reported to have kidney failure, which was not caused by the virus but rather by the effects of remdesivir.

Speaker 0: I had been on the front line in Miami, and my go-to is always vitamin C. Speaker 1: Do you take it orally or is that— Speaker 0: just Orly. Orly. Speaker 1: Orly. Is there a certain amount that you can take orally? Speaker 0: Well, I was taking a lot because I was exposed and I was worried. But then what I realized was I tested my sample, my scientist calls me and he goes, Did you notice your C? Did you notice your Bifidobacteria went up four times the level? What have you been doing? I go, Oh, I’ve been taking high dosages of vitamin C. And then he said to me, Well, you got to look into vitamin C. So right away, I switched my gears. As I’m dealing with treating COVID patients, as I’m dealing at looking at the stools before in high risk and severe, I switched my gears and I said, Okay, we need to call a bunch of naturopaths and send us patients before and after. So I started making phone calls again and said, I’ll pay for stool samples before and after on patients with vitamin C. And then we had like twenty, twenty five samples, and we noticed that the vitamin C increased Bifidobacteria. We published on that because actually vitamin C increases Bifidobacteria in vitro. So we published the paper to show that it increased in patients.

"Vitamin C improves gut Bifidobacteria in humans." "This was an incidental finding of my berythrombacteria increasing with vitamin C." "the only thing I've done different is I've been taking these enormous amounts of vitamin c." "Essentially, what we noticed was an increase in the bifidobacteria." "within twenty four hours of the infusion of the pills." "We created the Microbiome Research Foundation essentially to raise the funds to continue doing the research." "So when the vitamin C came on, it was really calling my colleagues and saying, have a protocol that is looking at the microbiome." "Our job was not to treat the kids." "We gave an informed consent." "we didn't need an IRB approved giving vitamin c to these kids." "We got these kids poop." "Our job was to look at what is vitamin c doing before and after." "before and after for nutraceuticals, pre and post vaccination, pre and post drugs, pre and post foods." "We tested 20 kids."

In 1970, a Japanese biochemist named Satoshi Omorra discovered a bacterium with intriguing effects against roundworm and shared it with American colleague William Campbell of Merck. Campbell used the bacterium to create ivermectin, released by Merck in 1980. Ivermectin proved extremely effective against river blindness (onchocerciasis), a disease caused by a parasitic worm that affected Central and South America and much of Africa. With ivermectin, river blindness has been largely eliminated in the Americas and greatly reduced in Africa. Billions of doses have been administered; it is listed among the World Health Organization’s essential medicines. Merck’s patent expired in 1996; the drug is cheap to produce, globally available in various formulations, and, at normal dosages, has no important side effects. In 2015, Omurra received the Nobel Prize for Medicine, shared with Campbell. Fast forward to early 2020, when the COVID-19 pandemic spread. Scientists searched for drugs with antiviral activity, and Monash University in Australia conducted a literature search that found ivermectin had shown activity against Zika, West Nile, and influenza. They performed experiments and found that ivermectin displays remarkable activity against SARS-CoV-2 in vitro, reporting a 5,000-fold reduction in viral levels after a single treatment without cytotoxicity, and proposed a mechanism for this effect. Around the same time, two American scientists noted that ivermectin was used as prophylaxis against river blindness in Africa and examined whether widespread ivermectin prophylaxis correlated with COVID-19 rates. They found that countries with extensive ivermectin prophylaxis had significantly lower COVID-19 rates. In Miami, Dr. Jean Jacques Reiter, a critical care and pulmonary specialist, treated COVID-19 patients with ivermectin after being urged by a patient’s son. He reported rapid improvement: the patient’s FiO2 requirements declined within 48 hours, and she was discharged within about a week. Reiter treated many patients with ivermectin and published a June 2020 preprint; he later testified before a Senate committee about his experiences. He stated that among hundreds of outpatients treated by his team, only two were admitted to the hospital; neither died or required intubation. Uncontrolled studies on ivermectin as prophylaxis and treatment circulated globally. A daughter described a care-home incident in Ontario, where residents on a floor receiving high-dose ivermectin for scabies reportedly had no COVID-19 infections among residents, even as staff on that floor became infected. In New York, Pierre Corry teamed with Reiter and Paul Merrick to form the Frontline COVID-19 Critical Care Alliance (FLCCC). In October 2020, the FLCCC released the Eye Mask Plus protocol, centering on ivermectin for prevention and treatment, and published a meta-analysis reviewing nine studies on prophylaxis and 12 studies on treatment, including seven randomized trials, all showing ivermectin’s superiority to controls. They presented figures showing reduced mortality and case rates associated with ivermectin use in various regions, including Peru, Mexico (Chiapas), and Argentina (healthcare workers). On December 8, 2020, FLCCC members appeared before a Senate subcommittee, with testimony claiming mountains of data showing ivermectin’s miraculous effectiveness and requesting the NIH to review their data. The transcript asserts widespread suppression of ivermectin information by mainstream media (New York Times, AP), big tech (YouTube, Twitter, Facebook), and the NIH. It alleges the NIH COVID-19 treatment guidelines panel, established in April 2020, largely recommended against early treatment and promoted remdesivir instead, even though remdesivir’s mortality impact was unproven and the World Health Organization advised against its use for improving survival. The panel’s treatment recommendations (as of 01/03/2021) are cited, highlighting monoclonal antibodies for early patients and no other treatments, except for remdesivir for deteriorating patients. Fauci publicly touted remdesivir’s endpoint as time to recovery, with the primary endpoint reportedly changed mid-trial from mortality to time to recovery, raising concerns about impartiality. The transcript traces remdesivir's production by Gilead Sciences and notes financial ties: seven panel members disclosed funding from Gilead; two of the three panel chairs received Gilead support, and Clifford Lane (one co-author on a remdesivir study) was closely connected to the study, with undisclosed ties among other authors. It argues these ties could impact decision-making and bias toward remdesivir over cheaper, repurposed drugs like ivermectin. The narrative then contrasts the U.S. approach with Uttar Pradesh, India, which authorized ivermectin as prophylaxis and treatment in August 2020. In January 2021, Uttar Pradesh reported near-zero COVID-19 deaths, while the United States faced ongoing high mortality, suggesting potential differential outcomes if ivermectin had been broadly authorized. The closing remarks emphasize the suffering caused by COVID-19 and its broad impacts on families and society.

The speaker discusses personal experiences with their microbiome and the role of vitamin C in recovering gut bacteria after a disruption. They note that when they killed their microbiome, they had zero, and then saw a reappearance of bacteria with vitamin C. They raise questions about whether remnants or precursor forms of bifidobacteria were missed by testing, and whether there are unknown factors from the microbiome that weren’t captured. They describe this as a future area of study: determining how much vitamin C to administer, for how long, and whether to use it short-term or long-term. The speaker shares their own recovery process after wiping out their microbiome, mentioning that it took a long time and involved tracking bifidobacteria until it stabilized. Once stability was achieved, they felt back to normal and stopped using supplements, returning to their pre-pandemic routine. They describe this as “refloralization,” a term they coined to describe bringing back the flora and microbes to resemble what they were before, acknowledging that no one has their exact pre-pandemic microbiome signature. They express hope that future efforts—ideally in collaboration with a government agency—will make stool assays available to the public so long-haulers can understand their gut health, including the status of bifidobacteria and how dietary factors might affect it. The speaker emphasizes that addressing long-hauler symptoms requires attention to bifidobacteria in the gut and understanding which foods promote or diminish it, including which meats are beneficial or not. They acknowledge that giving practical hints is complex because many factors influence bifidobacteria. They illustrate this with an analogy: a personal conflict the night before could reduce bifidobacteria, underscoring how daily events can impact gut health. The speaker also notes personal changes in temperament, describing themselves as previously a fireball who would engage in conflicts, but who has become calmer as stress responses shift, particularly in light of stressful news or retracted papers. They conclude with a sense of resilience, joking about not being overly affected by setbacks and maintaining confidence in their ongoing adaptation.

I worked in a small community hospital that cared for marginalized communities during COVID. I convinced the Chairman of the Board to turn the entire hospital into an ICU to handle the expected surge. I also founded the FLCCC with other doctors and developed the MathPlus protocol, which included cortisone agents, vitamin C, thiamine, heparin, and repurposed drugs like Ivermectin. Our success rate was remarkable, with a mortality rate of 4.4% compared to the national average of 25-40%. However, the media never focused on our achievements and I faced censorship on social media platforms. Many people died unnecessarily due to this censorship. The MathPlus protocol, along with good nursing and physician care, helped save lives, especially among indigent individuals who were critically ill when they arrived at the hospital.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like ivermectin, fenbendazole, and methylene blue, which was originally a textile dye but is now found to have significant effects on mitochondria. It's surprising how many effective treatments are overlooked or demonized, often due to profit motives. Many beneficial substances, such as vitamin D, K2, magnesium, zinc, and quercetin, are not promoted because they lack patent protection and cannot be controlled by pharmaceutical companies.

The dialogue centers on treatments and outcomes for COVID-19, with concerns about what is being used and what might work. One participant remarks on the reluctance to use certain treatments that are successful worldwide, recounting a conversation with a doctor. Another asks what kinds of treatments are being tried, noting that some approaches “are coming out with different things that are in the testing phase.” A third person criticizes a platform they believe “kills more people than actually save,” and another agrees that “they don’t work anyway,” questioning the harm in trying alternatives when current efforts aren’t effective. A key exchange discusses expectations for patient survival. One person says, “I don’t expect any of these people to survive. Ninety percent of them would die,” while another adds that if patients are “already dying anyway,” it may be reasonable to try additional measures rather than do nothing. There is debate about whether trying unproven treatments is appropriate; one participant notes that without a scientific basis, extra attempts can make patients worse, while another concedes that they would try anything to save their life. The conversation then shifts to clinical presentations and treatment strategies. With COVID patients who cannot breathe, X-rays show “the lungs are white,” indicating affected lungs with very thick, white secretions. The question arises of what “white lung” means—whether it is mucus and coating that fill the lungs and impede oxygen transfer. In response, the discussion distinguishes between early-stage treatments (like hydroxychloroquine and zinc) and later-stage interventions. It is stated that once lungs are severely affected, certain proven treatments exist that have passed trials in Asia through Dr. Chang, described as a US-board-certified physician. Specifically, extremely high-dose IV vitamin C is claimed to be successful in treating patients, providing the lungs with antioxidant support to help expel the infection, alongside IV antibiotics to treat the infection while avoiding reliance on ventilation and sedation. There is a contrast drawn between approaches in different regions. The dialogue notes that high-dose IV vitamin C has passed three trials in Asia and is reported as effective, while in the speaker’s locale, there is hesitation or reluctance to adopt this method. The discussion ends with a remark about how some people might attribute success to “good genes,” implying a belief that genetics may influence susceptibility or outcomes, though this is stated rather than argued as a scientific conclusion. Overall, the conversation emphasizes that several participants are wary of conventional treatments, advocate for exploring high-dose IV vitamin C as a therapeutic option, and describe the characteristic radiographic and clinical features of severe COVID-19 lung involvement.

Once it was determined to be safe, the speaker began using a treatment and found that it worked. Over 6,000 patients were treated, and those who received early treatment avoided hospitalization. Some patients came in very sick in their second week, with oxygen saturation in the low 80s, refusing to go to the hospital. The speaker's office offered them the option to possibly die there. They treated these patients with IV steroids, IV antibiotics, home oxygen, and high doses of ivermectin, without using monoclonal antibodies, and the patients were saved.

According to the speaker, hospital protocols differed for vaccinated and unvaccinated COVID-19 patients, with more aggressive protocols used on the unvaccinated. The unvaccinated patients interviewed were often given remdesivir, a repurposed drug from a failed Ebola trial where about half the patients died. The speaker claims the efficacy data for remdesivir was "sketchy at best," but hospitals received large reimbursements for its use. The speaker alleges that patients would then be put on oxygen, then mechanical ventilation, then ICU, and finally, if they resisted, a cocktail of sedatives and sometimes four-point restraints to prevent them from leaving. The speaker states that "a lot of the patients died." The speaker claims that at each step, the hospital received more reimbursement, and there was "lockstep adherence" to the protocol.